HER2 Support Group Forums - View Single Post

Christine MH-UK · 11-26-2008, 01:27 PM

The percentage of people who got herceptin only after chemo and thereby avoided a recurrence in the HERA trial's one year followup was 8 percentage points (something like a halving of risk from a sixteen percent chance of recurrence down to 8 percent). Since only about a quarter of UK patients are Her2-positive, based on these results herceptin used after chemo would reduce the recurrence rate of all breast cancer patients in the UK by two percentage points. This is the only 2% I can think of, but it really isn't relevant to your situation.

11-26-2008, 01:27 PM	#7
Christine MH-UK Senior Member Join Date: Sep 2005 Posts: 414	Figured out what that 2% might be The percentage of people who got herceptin only after chemo and thereby avoided a recurrence in the HERA trial's one year followup was 8 percentage points (something like a halving of risk from a sixteen percent chance of recurrence down to 8 percent). Since only about a quarter of UK patients are Her2-positive, based on these results herceptin used after chemo would reduce the recurrence rate of all breast cancer patients in the UK by two percentage points. This is the only 2% I can think of, but it really isn't relevant to your situation.